中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 6
Jun.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(6): 1196-1202

Risk factors for pulmonary infection in patients with acute-on-chronic liver failure and establishment of a predictive model

DOI: 10.12449/JCH240620

  • Department of Infectious Diseases，The Second Affiliated Hospital of Air Force Medical University，Xi’an 710038，China

Research funding:

Social Talent Fund Program of the Second Affiliated Hospital of Air Force Medical University (2021SHRC057)

More Information
  • Corresponding author: DANG Xiao， 513307098@qq.com （ORCID： 0000-0001-5124-8047）
  • Received Date: 2023-09-07
  • Accepted Date: 2023-11-14
  • Published Date: 2024-06-25
    Abstract
  •   Objective  To investigate the risk factors for pulmonary infection in patients with acute-on-chronic liver failure （ACLF）， and to establish a predictive model.  Methods  A retrospective analysis was performed for 585 ACLF patients who were admitted to Department of Infectious Diseases， The Second Affiliated Hospital of Air Force Medical University， from January 2009 to September 2022， and according to the condition of pulmonary infection after admission， they were divided into infection group with 213 patients and non-infection group with 372 patients. The independent-samples t test or the Mann-Whitney U test was used for comparison of continuous data between two groups， and the chi-square test was used for comparison of categorical data between groups. The clinical data of these patients were collected. Univariate and multivariate Logistic regression analyses were used to investigate the risk factors for pulmonary infection in ACLF patients and establish a predictive model， and the receiver operating characteristic （ROC） curve was plotted to assess the predictive value of the model. The Hosmer-Lemeshow test was used to evaluate the degree of fitting of the model， and the ROC curve and the area under the ROC curve （AUC） were used to assess the predictive performance of the model.  Results  Among the 585 patients with ACLF， 213 experienced pulmonary infection， with an infection rate of 36.41%. The multivariate logistic analysis showed that upper gastrointestinal bleeding （odds ratio ［OR］=2.463， P=0.047）， infection at other sites （OR=2.218， P=0.004）， femoral vein catheterization （OR=2.520， P<0.001）， and combined use of two or more antibiotics （OR=2.969， P<0.001） were risk factors for pulmonary infection in ACLF patients. These factors were included in the risk factor predictive model of Logit （P）=-1.869+0.901×upper gastrointestinal bleeding+0.755×infection at other sites+0.924×femoral vein catheterization+1.088×combined use of two or more antibiotics. The ROC curve analysis showed that the model had a good predictive value （Hosmer-Lemeshow χ2=3.839， P=0.698）， with an AUC of 0.753 （95% confidence interval： 0.700 — 0.772）.  Conclusion  There is a relatively high incidence rate of pulmonary infection in patients with ACLF， and upper gastrointestinal bleeding， spontaneous peritonitis， femoral vein catheterization， and combined use of two or more antibiotics are related risk factors. The model established based on these factors can effectively predict the onset of pulmonary infection in ACLF patients.

     

    • FullText(HTML)
  • loading
    • References(24)
  • [1]
    Liver Failure and Artificial Liver Group, Chinese Society of lnfectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.

    中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
    [2]
    CHEN MJ, LI X, TANG SH. Research progress on multidimensional evaluation of liver function in the prognosis of liver failure patients[J]. Clin J Med Offic, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05.

    陈美娟, 李雪, 汤善宏. 多维度评估肝功能在肝衰竭患者预后中研究进展[J]. 临床军医杂志, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05.
    [3]
    ZULIPIYA AHMTHT. Analysis of risk factors and control measures for severe hepatitis with pulmonary infection[J]. World Latest Med Inf, 2018, 18( 90): 23- 24, 28. DOI: 10.19613/j.cnki.1671-3141.2018.90.012.

    祖丽皮娅·艾合麦托合提. 重型肝炎合并肺部感染患者相关危险因素的分析以及防治对策[J]. 世界最新医学信息文摘, 2018, 18( 90): 23- 24, 28. DOI: 10.19613/j.cnki.1671-3141.2018.90.012.
    [4]
    CHEN MS, GAN QR, JIANG XY, et al. Clinical analysis of pulmonary infection in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Chin J Infect Dis, 2015, 33( 4): 193- 197. DOI: 10.3760/cma.j.issn.1000-6680.2015.04.001.

    陈明胜, 甘巧蓉, 江晓燕, 等. 乙型肝炎病毒相关慢加急性肝功能衰竭患者合并肺部感染的临床分析[J]. 中华传染病杂志, 2015, 33( 4): 193- 197. DOI: 10.3760/cma.j.issn.1000-6680.2015.04.001.
    [5]
    RODRÍGUEZ-OTERO P, MATEOS MV, MARTÍNEZ-LÓPEZ J, et al. Early myeloma-related death in elderly patients: Development of a clinical prognostic score and evaluation of response sustainability role[J]. Leukemia, 2018, 32( 11): 2427- 2434. DOI: 10.1038/s41375-018-0072-6.
    [6]
    Infectious Diseases Group, Respiratory Disease Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults in China(2018)[J]. Chin J Tuberc Respir Dis, 2018, 41( 4): 255- 280. DOI: 10.3760/cma.j.issn.1001-0939.2018.04.006.

    中华医学会呼吸病学分会感染学组. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)[J]. 中华结核和呼吸杂志, 2018, 41( 4): 255- 280. DOI: 10.3760/cma.j.issn.1001-0939.2018.04.006.
    [7]
    ZHOU XS, CHEN XY, DU HJ, et al. Antithrombin III activity is associated with prognosis, infection, and inflammation in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Eur J Gastroenterol Hepatol, 2023, 35( 8): 914- 920. DOI: 10.1097/MEG.0000000000002571.
    [8]
    LIU YD, SUN SS, XU H, et al. Analysis of infection characteristics and risk factors in patients with HBV-related chronic and acute liver failure[J]. Chin Hepatol, 2019, 24( 9): 1015- 1019. DOI: 10.14000/j.cnki.issn.1008-1704.2019.09.013.

    刘亚迪, 孙双双, 徐浩, 等. HBV相关慢加急性肝衰竭患者感染特点及危险因素分析[J]. 肝脏, 2019, 24( 9): 1015- 1019. DOI: 10.14000/j.cnki.issn.1008-1704.2019.09.013.
    [9]
    CHEN EQ, ZENG F, ZHOU LY, et al. Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure[J]. World J Gastroenterol, 2015, 21( 42): 11964- 11973. DOI: 10.3748/wjg.v21.i42.11964.
    [10]
    HU ZC, CHEN Y. Study on influencing factors of pulmonary infection in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Chin J Nurs, 2020, 55( 10): 1521- 1526. DOI: 10.3761/j.issn.0254-1769.2020.10.014.

    胡正翠, 陈怡. 慢加急性肝衰竭患者发生肺部感染的现状及影响因素研究[J]. 中华护理杂志, 2020, 55( 10): 1521- 1526. DOI: 10.3761/j.issn.0254-1769.2020.10.014.
    [11]
    ZOU LK, DENG ZT, CHEN LN. Diagnostic value of alveolar lavage fluid and sputum pathogen culture in lower respiratory tract infection[J]. J Prev Med Chin People’s Liberation Army, 2019, 37( 5): 19- 20. DOI: 10.13704/j.cnki.jyyx.2019.05.009.

    邹兰科, 邓忠天, 陈丽娜. 肺泡灌洗液和痰病原菌培养对下呼吸道感染的诊断价值分析[J]. 解放军预防医学杂志, 2019, 37( 5): 19- 20. DOI: 10.13704/j.cnki.jyyx.2019.05.009.
    [12]
    CAO ZJ, LIU YH, ZHU CW, et al. Bacterial infection triggers and complicates acute-on-chronic liver failure in patients with hepatitis B virus-decompensated cirrhosis: A retrospective cohort study[J]. World J Gastroenterol, 2020, 26( 6): 645- 656. DOI: 10.3748/wjg.v26.i6.645.
    [13]
    GUSTOT T, MAILLART E, BOCCI M, et al. Invasive aspergillosis in patients with severe alcoholic hepatitis[J]. J Hepatol, 2014, 60( 2): 267- 274. DOI: 10.1016/j.jhep.2013.09.011.
    [14]
    LI PB, QIN FB, GONG JP. Association between intestinal barrier and bacterial translocation in patients with liver cirrhosis[J]. J Clin Hepatol, 2019, 35( 8): 1854- 1857. DOI: 10.3969/j.issn.1001-5256.2019.08.046.

    李佩波, 秦凡博, 龚建平. 肝硬化患者肠道屏障与细菌易位的关系[J]. 临床肝胆病杂志, 2019, 35( 8): 1854- 1857. DOI: 10.3969/j.issn.1001-5256.2019.08.046.
    [15]
    DAI JF, DAI WM, QI DJ, et al. Risk factors for postoperative pulmonary infection in patients with craniocerebral injury and establishment of prediction model[J]. Chin J Nosocomiology, 2021, 31( 7): 1034- 1038. DOI: 10.11816/cn.ni.2021-201932.

    戴俊芬, 戴伟民, 戚东静, 等. 颅脑损伤开颅术后肺部感染危险因素分析及预测模型构建[J]. 中华医院感染学杂志, 2021, 31( 7): 1034- 1038. DOI: 10.11816/cn.ni.2021-201932.
    [16]
    AHMAD CHEEMA H, SHAHID A, AYYAN M, et al. Probiotics for the prevention of ventilator-associated pneumonia: An updated systematic review and meta-analysis of randomised controlled trials[J]. Nutrients, 2022, 14( 8): 1600. DOI: 10.3390/nu14081600.
    [17]
    KLOMPAS M, BRANSON R, EICHENWALD EC, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update[J]. Infect Control Hosp Epidemiol, 2014, 35( 8): 915- 936. DOI: 10.1086/677144.
    [18]
    TAO N, GAO W, QIN GM. Establishment and verification of nomogram model for individualized prediction of risk for pulmonary infection in elderly patients with acute myocardial infarction after percutaneous coronary intervention[J]. Chin J Infect Contr, 2022, 21( 3): 261- 267.

    陶娜, 高伟, 秦国民. 个体化预测老年急性心肌梗死患者PCI术后肺部感染风险列线图模型的建立与验证[J]. 中国感染控制杂志, 2022, 21( 3): 261- 267.
    [19]
    ZHANG Z, ZHU J, DOU Y. Effect of artificial liver plasma exchange combined with CRRT in the treatment of hepatitis B-related chronic acute liver failure complicated with acute renal failure and its impact on prognosis[J]. Clin Misdiagn Misther, 2023, 36( 10): 86- 90. DOI: 10.3969/j.issn.1002-3429.2023.10.019.

    张泽, 朱健, 窦燕. 人工肝血浆置换联合CRRT治疗乙肝相关慢加急性肝衰竭合并急性肾衰竭效果及对预后的影响[J]. 临床误诊误治, 2023, 36( 10): 86- 90. DOI: 10.3969/j.issn.1002-3429.2023.10.019.
    [20]
    CHANG WJ, CIRENYANGJIN, NI MPD, et al. Current status of catheter infection with deep venous catheterization in hemodialysis patients[J]. J Nurs Adm, 2019, 19( 12): 878- 880. DOI: 10.3969/j.issn.1671-315x.2019.12.009.

    常文静, 次仁央金, 尼玛片多, 等. 血液透析深静脉置管患者导管感染现状研究[J]. 护理管理杂志, 2019, 19( 12): 878- 880. DOI: 10.3969/j.issn.1671-315x.2019.12.009.
    [21]
    ZHOU JP, HUANG W, ZHENG SY, et al. Etiological characteristics and influencing factors for central venous catheter-related bloodstream infection in hemodialysis patients[J]. Chin J Nosocomiology, 2023, 33( 9): 1338- 1341.

    周建平, 黄文, 郑淑瑛, 等. 血液透析患者中心静脉置管相关血流感染的病原学特点和影响因素[J]. 中华医院感染学杂志, 2023, 33( 9): 1338- 1341.
    [22]
    MIAO YQ, LIU WW, ZHAO SL, et al. Construction and validation of risk prediction model for umbilical vein catheterization bloodstream infection in neonates in neonatal intensive care unit[J]. Chin J Infect Contr, 2023, 22( 2): 159- 166. DOI: 10.12138/j.issn.1671-9638.20233383.

    苗逸群, 刘文文, 赵淑良, 等. NICU新生儿脐静脉置管血流感染风险预测模型的构建与验证[J]. 中国感染控制杂志, 2023, 22( 2): 159- 166. DOI: 10.12138/j.issn.1671-9638.20233383.
    [23]
    Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Expert consensus on clinical application of artificial liver and blood purification(2022 edition)[J]. J Clin Hepatol, 2022, 38( 4): 767- 775. DOI: 10.3969/j.issn.1001-5256.2022.04.007.

    中华医学会肝病学分会重型肝病与人工肝学组. 人工肝血液净化技术临床应用专家共识(2022年版)[J]. 临床肝胆病杂志, 2022, 38( 4): 767- 775. DOI: 10.3969/j.issn.1001-5256.2022.04.007.
    [24]
    Society of Infectious Diseases, Chinese Medical Association. Expert consensus on diagnosis and treatment of end-stage liver disease complicated with infections(2021 version)[J]. J Clin Hepatol, 2022, 38( 2): 304- 310. DOI: 10.3969/j.issn.1001-5256.2022.02.010.

    中华医学会感染病学分会. 终末期肝病合并感染诊治专家共识(2021年版)[J]. 临床肝胆病杂志, 2022, 38( 2): 304- 310. DOI: 10.3969/j.issn.1001-5256.2022.02.010.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (191) PDF downloads(32) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return